We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 125 results

  1. Neuroprotektive Therapien bei idiopathischen, genetischen und atypischen Parkinson-Syndromen mit α-Synuklein – Pathologie

    The key aspect of the classification of neurodegenerative diseases is the histopathological detection of certain proteins in the brain. The various...

    Johannes Levin, Georg Nübling, ... Wolfgang Oertel in Der Nervenarzt
    Article Open access 04 November 2021

  3. In Sichtweite – ein Bluttest für Parkinson

    B. Falkenburger in DGNeurologie
    Article 13 April 2023

  4. Parkinsondiagnose per Blutuntersuchung

    Daniela Berg, Max Borsche in InFo Neurologie + Psychiatrie
    Article 21 September 2023

  6. Therapie – Quo vadis Neurodegeneration?

    Background

    Hallmarks of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease are pathological protein aggregation,...

    Jonathan Vöglein, Johannes Levin, Günter Höglinger in Der Nervenarzt
    Article 06 October 2023

  8. Parkinson- und Alzheimer-Erkrankung als Systemerkrankungen

    Background

    Parkinson’s and Alzheimer’s disease (PD/AD) are characterized by cellular pathological changes that precede clinical manifestation and...

    Thorsten Bartsch, Daniela Berg, ... Frank Leypoldt in Der Nervenarzt
    Article 06 September 2023

  9. Fokus atypische Parkinsonsyndrome: Teil 1 – Multisystematrophie

    Multisystem atrophy is a neurodegenerative disorder belonging to the atypical Parkinsonian syndromes and is rare with an incidence of 5/100,000. It...

    C. Jacksch, S. Paschen, D. Berg in DGNeurologie
    Article 13 June 2023

  10. Zusammenhänge zwischen Mikrobiom und Neurodegeneration

    Background

    Neurodegenerative diseases are often associated with changes in the (gut) microbiome.

    Objective

    Based on studies in Parkinson’s disease...

    Corinna Bang, Sebastian Heinzel in Der Nervenarzt
    Article 06 September 2023

  11. Schlafstörungen bei Parkinson-Krankheit

    Sleep of patients with Parkinson’s disease (PD) is affected by both motor and non-motor symptoms; the neurodegeneration causes alterations in...

    Kirsi Lange, Jan Simon Gerdes, Berthold Voges in Somnologie
    Article 12 February 2024

  12. Dysphagie bei Parkinson-Syndromen

    Dysphagia is a clinically relevant problem in Parkinson’s disease as well as in atypical Parkinsonian syndromes, such as multiple system atrophy and...

    F. Gandor, L. Berger, ... I. Claus in Der Nervenarzt
    Article 28 April 2023

  13. Mitteilungen der DGN

    in Der Nervenarzt
    Article 03 February 2023

  16. Prognostischer und differenzialdiagnostischer Stellenwert der Liquordiagnostik bei neurodegenerativen Demenzerkrankungen

    Cerebrospinal fluid (CSF) analysis is an important diagnostic tool in the assessment of dementia. For the differentiation of Alzheimer’s disease from...

    R. Haußmann, P. Homeyer, ... M. Donix in Der Nervenarzt
    Article Open access 07 June 2022

  17. Atypische Parkinson-Syndrome im Alter

    Atypical Parkinson syndromes represent a neuropathologically heterogeneous group and include the clinical entities dementia with Lewy bodies (DLB),...

    Bernhard Iglseder, Rüdiger Lange in Zeitschrift für Gerontologie und Geriatrie
    Article 24 June 2022

  18. Proteinbezogene Therapien neurodegenerativer Erkrankungen

    Johannes Levin, Wolfgang Oertel in Der Nervenarzt
    Article 06 December 2021

  19. Parkinson-Krankheit

    Parkinson’s disease (PD) is an unparalleled example of a neurodegenerative disorder that can be effectively managed leading to sustained symptom...

    Tobias Warnecke, Carina Lummer, ... Dieter Lüttje in Die Innere Medizin
    Article 08 December 2022

  20. „Keine Kapitulation vor den Schrecken der Dunkelheit!“

    Thomas Meißner in CME
    Article 11 March 2024
Did you find what you were looking for? Share feedback.